Mesoblast
MESO
#5108
Rank
$1.81 B
Marketcap
$13.96
Share price
-2.17%
Change (1 day)
-23.04%
Change (1 year)

Operating Margin for Mesoblast (MESO)

Operating Margin at the end of 2026: -47.31%

According to Mesoblast 's latest financial reports and stock price the company's current Operating Margin is -47.30%. At the end of 2026 the company had an Operating Margin of -47.31%.

Operating Margin history for Mesoblast from 2005 to 2026

Operating Margin at the end of each year

Year Operating Margin Change
2026-47.31%-92.01%
2025-592.00%-60.36%
2024-1,493.51%36.45%
2023-1,094.53%22.03%
2022-896.93%-33.07%
2021-1,340.19%385.02%
2020-276.32%-53.21%
2019-590.56%51.94%
2018-388.67%-91.62%
2017-4,640.69%2018.95%
2016-219.01%-55.03%
2015-487.04%50.83%
2014-322.92%54.72%
2013-208.71%63.44%
2012-127.70%-267.33%
201176.32%-103.95%
2010-1,932.36%-70.7%
2009-6,594.63%496.26%
2008-1,105.99%112.8%
2007-519.74%76.73%
2006-294.09%0.58%
2005-292.39%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Nymox Pharmaceutical
NYMX
-234,760.00% 496,221.35% Bahamas
NRC Health
NRC
12.98%-127.44%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.